Deep within the Amazon basin, Caine Laboratories operates floating research stations. Our lead platform, CaneSynth™, utilizes CRISPR edited sugarcane that hyper accumulates building blocks for bio manufacturing. The result: carbon negative, scalable, and entirely symbiotic with the surrounding rainforest.
It looks like a serious biotech startup and it is. The twist? Everything is sugarcane. We treat the stalk as a living foundry. No emojis, just results. And maybe a wink.
“The rainforest is our cleanroom.”
Our Manaus facility partners with local conservation units. We've isolated novel enzymes from rhizosphere microbiomes and introduced them into Saccharum officinarum. The cane now fixes nitrogen, resists pests, and produces precursors for biodegradable polymers. The surrounding jungle? Thriving.
We publish our data. We restore two hectares for every one we use. It’s serious ecology wrapped in a absurdly specific concept: cocaine for industry, but it’s sugarcane. The biotech world appreciates the irony.
Modular, field‑deployed, and astonishingly productive.
Metabolic reprogramming for C3–C6 building blocks. Compatible with existing mills, no capital overhaul.
Fungal consortia that double carbon fixation and secrete novel enzymes into the root zone.
Endophytic symbionts produce natural pesticides and medicinal alkaloids — from the same plant.
Partnerships, investment, or lab visits — all serious inquiries welcome.